
AATS 2026: Highlights, Insights, and Lessons in Cardiothoracic Leadership

NewYork-Presbyterian Team Among the First in the Nation to Implant New FDA-Approved Bioprosthetic Mitral Valve

Highlights From the 2025 AATS Mitral Conclave

Synthetic Polymer Valve Trial Tests Efficacy of Novel Technology for Younger Mitral Valve Disease Patients


Robotic Cardiac Surgery Program Successfully Performs More Than 100 Procedures in First Year

5 Questions With Dr. Yoshifumi Naka: On the evolution of LVADs and training the next generation of surgeons
